We are at AD/PD 2024 – March 5-9, 2024, Lisbon, Booth #19 | Poster #0235: Non-invasive detection of AD biomarkers for differentiation of AD in cognitively impaired patients Learn More

Uncovering the Secret

We strive for better diagnosis, understanding and treatment of neurodegenerative diseases based on nasal secretion.

We are at AD/PD 2024
March 5-9, 2024, Lisbon, Booth #19 | Poster #0235

Diagnostic Platform

Detailed proteomic analysis of nasal secretion to enable accurate diagnosis of neurodegenerative diseases and possible early detection.

Diagnostic Service

Provision of diagnostic tests for screening, diagnosing and monitoring neurodegenerative diseases. Discover our first clinical target: Alzheimer’s Disease.

Biopharma Services

We will provide dedicated diagnostic and data services to support your needs from discovery to clinical development in the field of neurodegenerative diseases.

Clinical Trials

We are conducting several multi-centric studies across the country to empower the development of our groundbreaking diagnostic solutions and to support our research activities.

About Noselab

Learn more about us, our network and our vision!

All provided information and content of this website is for healthcare professionals only.